AXS Investments’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $322K | Sell |
795
-2,827
| -78% | -$1.15M | 0.13% | 132 |
|
|
2025
Q1 | $1.8M | Sell |
3,622
-3,993
| -52% | -$1.99M | 0.5% | 55 |
|
|
2024
Q4 | $3.96M | Buy |
7,615
+1,818
| +31% | +$946K | 1.1% | 16 |
|
|
2024
Q3 | $3.59M | Buy |
5,797
+2,542
| +78% | +$1.57M | 0.95% | 17 |
|
|
2024
Q2 | $1.8M | Sell |
3,255
-273
| -8% | -$151K | 0.5% | 73 |
|
|
2024
Q1 | $2.05M | Sell |
3,528
-178
| -5% | -$103K | 0.49% | 54 |
|
|
2023
Q4 | $1.97M | Buy |
3,706
+144
| +4% | +$76.4K | 0.47% | 62 |
|
|
2023
Q3 | $1.8M | Sell |
3,562
-277
| -7% | -$140K | 0.47% | 63 |
|
|
2023
Q2 | $2M | Buy |
3,839
+195
| +5% | +$102K | 0.53% | 40 |
|
|
2023
Q1 | $2.1M | Sell |
3,644
-94
| -3% | -$54.2K | 0.69% | 30 |
|
|
2022
Q4 | $2.06M | Buy |
3,738
+201
| +6% | +$111K | 0.74% | 28 |
|
|
2022
Q3 | $1.79M | Sell |
3,537
-394
| -10% | -$200K | 0.7% | 31 |
|
|
2022
Q2 | $2.14M | Buy |
3,931
+1,235
| +46% | +$671K | 0.76% | 29 |
|
|
2022
Q1 | $1.59M | Sell |
2,696
-990
| -27% | -$585K | 0.63% | 41 |
|
|
2021
Q4 | $2.46M | Buy |
3,686
+2,889
| +362% | +$1.93M | 0.58% | 54 |
|
|
2021
Q3 | $455K | Sell |
797
-3,350
| -81% | -$1.91M | 0.17% | 59 |
|
|
2021
Q2 | $2.09M | Sell |
4,147
-1,211
| -23% | -$611K | 0.64% | 41 |
|
|
2021
Q1 | $2.45M | Buy |
+5,358
| New | +$2.45M | 0.87% | 35 |
|